SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001140361-24-024747
Filing Date
2024-05-07
Accepted
2024-05-07 19:19:08
Documents
1
Group Members
KNIGHT THERAPEUTICS INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A ef20028560_sc13ga.htm SC 13G/A 81891
  Complete submission text file 0001140361-24-024747.txt   83698
Mailing Address DR LUIS BONAVITA 1294 OFFICE 2004 MONTEVIDEO X3 11300
Business Address DR LUIS BONAVITA 1294 OFFICE 2004 MONTEVIDEO X3 11300 982-626-2344
KNIGHT THERAPEUTICS INTERNATIONAL SA (Filed by) CIK: 0001632373 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X3 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 202-327-5422
60 DEGREES PHARMACEUTICALS, INC. (Subject) CIK: 0001946563 (see all company filings)

IRS No.: 452406880 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-94258 | Film No.: 24923767
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)